CSIR-IIIM & HAPICO Industries Forge Alliance
ECONOMY & POLICY

CSIR-IIIM & HAPICO Industries Forge Alliance

In a landmark move fostering industry-academia collaboration, the CSIR - Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, has signed a Memorandum of Understanding (MoU) with HAPICO Industries Pvt. Ltd. on 20 March 2025 to develop novel biopesticides.

Harnessing Nature for Sustainable Agriculture The partnership aims to mitigate the harmful effects of chemical pesticides by leveraging India’s rich biodiversity of medicinal and aromatic plants. The focus will be on formulating biopesticides derived from indigenous microbial strains identified by CSIR-IIIM.

Key Stakeholders & Vision

Dr Zabeer Ahmed, Director, CSIR-IIIM, reaffirmed the institute’s commitment to translational and sustainable research, ensuring direct benefits for farmers. Mr. Shabeer Ahmed, MD, HAPICO Industries, highlighted the collaboration as a strategic initiative to expand their product portfolio and align with evolving market demands. Dr Asha Chaubey, Head, FMB Division, emphasized the role of advanced microbial technology in developing eco-friendly agricultural solutions.

Advancing Agro-Technology CSIR-IIIM, with its state-of-the-art fermentation and microbial research infrastructure, is actively engaged in developing: Plant growth-promoting products Active Pharmaceutical Ingredients (APIs) Enzymes & Biocontrol formulations

This scientific-industrial alliance marks a crucial step towards eco-friendly pest management, reinforcing India’s commitment to sustainable agriculture and green innovation.

In a landmark move fostering industry-academia collaboration, the CSIR - Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu, has signed a Memorandum of Understanding (MoU) with HAPICO Industries Pvt. Ltd. on 20 March 2025 to develop novel biopesticides. Harnessing Nature for Sustainable Agriculture The partnership aims to mitigate the harmful effects of chemical pesticides by leveraging India’s rich biodiversity of medicinal and aromatic plants. The focus will be on formulating biopesticides derived from indigenous microbial strains identified by CSIR-IIIM. Key Stakeholders & Vision Dr Zabeer Ahmed, Director, CSIR-IIIM, reaffirmed the institute’s commitment to translational and sustainable research, ensuring direct benefits for farmers. Mr. Shabeer Ahmed, MD, HAPICO Industries, highlighted the collaboration as a strategic initiative to expand their product portfolio and align with evolving market demands. Dr Asha Chaubey, Head, FMB Division, emphasized the role of advanced microbial technology in developing eco-friendly agricultural solutions. Advancing Agro-Technology CSIR-IIIM, with its state-of-the-art fermentation and microbial research infrastructure, is actively engaged in developing: Plant growth-promoting products Active Pharmaceutical Ingredients (APIs) Enzymes & Biocontrol formulations This scientific-industrial alliance marks a crucial step towards eco-friendly pest management, reinforcing India’s commitment to sustainable agriculture and green innovation.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code